Evidence map›Paper›PMID 39814789›Full record

ArticleScientific reports2025

Mutated IL-32θ (A94V) inhibits COX2, GM-CSF and CYP1A1 through AhR/ARNT and MAPKs/NF-κB/AP-1 in keratinocytes exposed to PM

Jinju Kim, Chae-Min Lim, Nahyun Kim, Hong-Gyum Kim, Jin-Tae Hong, Young Yang, Do-Young Yoon

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jinju KimDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.ORCID 0000-0003-1238-1827
Chae-Min LimDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.ORCID 0000-0002-3138-1147
Nahyun KimDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.ORCID 0009-0001-6194-8474
Hong-Gyum KimBoson Bioscience, Cheongju, 28161, Chungbuk, Republic of Korea.ORCID 0000-0003-4262-1916
Jin-Tae HongCollege of Pharmacy & Medical Research Center, Chungbuk National University, Cheongju, 28160, Republic of Korea.ORCID 0000-0002-6534-9575
Young YangSookmyung Women's University, Seoul, 04310, Republic of Korea. yyang@sookmyung.ac.kr.ORCID 0000-0003-4239-0804
Do-Young YoonDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. ydy4218@konkuk.ac.kr.ORCID 0000-0002-0154-614X

Funding

National Research Foundation of Korea NRF-2021R1A2C3003414 and NRF-2021R1A6A1A03038890National Research Foundation of Korea RS-2024-00451912
6 · The paper itself

Abstract

Exposure to particulate matter (PM) in the air harms human health. Most studies on particulate matter's (PM) effects have primarily focused on respiratory and cardiovascular diseases. Recently, IL-32θ, one of the IL-32 isoforms, has been demonstrated to modulate cancer development and inflammatory responses. This study revealed that one-point mutated IL-32θ (A94V) plays an important role in attenuating skin inflammation. IL-32θ (A94V) inhibited PM-induced COX-2, a pro-inflammatory cytokine GM-CSF and CYP1A1 in PM-exposed human keratinocytes HaCaT cells. IL-32θ (A94V) modulating effects were mediated via down-regulating ERK/p38/NF-κB/ AP-1 and AhR/ARNT signaling pathways. Our study indicates that PM triggers skin inflammation by upregulating COX-2, GM-CSF and CYP1A1 expression. IL-32θ (A94V) suppresses the expressions of COX-2, GM-CSF, and CYP1A1 by blocking the nuclear translocation of NF-κB and AP-1, as well as inhibiting the activation of the AhR/ARNT signaling pathway. Our findings offer valuable insights into developing therapeutic strategies and potential drugs to mitigate PM-induced skin inflammation by inhibiting the ERK/p38/NF-κB/AP-1 and AhR/ARNT signaling pathways.

Indexed as

Cyclooxygenase 2Cytochrome P-450 CYP1A1Granulocyte-Macrophage Colony-Stimulating FactorInterleukinsKeratinocytesParticulate MatterBasic Helix-Loop-Helix ProteinsCell LineHaCaT CellsHumansMutationNF-kappa BReceptors, Aryl HydrocarbonSignal TransductionTranscription Factor AP-1AHR protein, humanBasic Helix-Loop-Helix ProteinsCyclooxygenase 2CYP1A1 protein, humanCytochrome P-450 CYP1A1Granulocyte-Macrophage Colony-Stimulating FactorIL32 protein, humanInterleukinsNF-kappa BParticulate MatterPTGS2 protein, humanReceptors, Aryl HydrocarbonTranscription Factor AP-1Fine dustHaCaTMAPKone-point mutated IL-32θ (A94V)PAHPM10Skin inflammation

Identifiers

PMID39814789
PMCPMC11735608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.